VeraFab
VeraFab is rebuilding flow cytometry on semiconductor physics, using silicon photonics and microfluidics to deliver EuroFlow immunophenotyping on a €6.0k benchtop reader with single-use chips. The company's analysis software is live today, while the instrument is in design, targeting labs that currently rely on six-figure conventional or spectral cytometers.
- Medical Devices
- Healthcare Technology
- Semiconductor
- Artificial Intelligence
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Conventional flow cytometers are bulky, six-figure instruments that require a dedicated room and a trained specialist to operate. Samples must queue for a shared machine in a central lab, and the results come back in a format built for a person to read, not for a model to learn from—stalling the loop between hypothesis and data, especially as biology moves into manufacturing suites, automated pipelines, and clinics far from core facilities.
Solution
VeraFab is redesigning the flow cytometer using semiconductor physics: silicon photonics for optics, microfluidics to line cells up one at a time, and AI to design the instrument itself and interpret the data. The target is the marker depth of a spectral cytometer costing £350,000, delivered on a chip in a box that sits on a bench. The reader runs EuroFlow panels with a single-use chip, a lighter reagent load, and no service contract, producing results that are standardized by construction across every unit and site. Analysis software is live today; the instrument is in design.
Target Audience
Clinical haematology labs running EuroFlow panels on conventional or spectral cytometers—including BD FACSCanto/FACSLyric and Cytek Aurora users—who need EuroFlow-class immunophenotyping in decentralised settings at lower cost.
Features
- Single-use silicon-photonics chip that performs EuroFlow immunophenotyping on a ~€6.0k benchtop reader, replacing multi-tube reagent loads with one chip
- AI-designed instrument and AI-driven readout that standardizes results and reduces the interpretation gap between bench and referring clinician
- Factory-calibrated readout delivers cross-site reference-range consistency by construction, with an automated daily QC report
- Replaces most antibody-reagent, service-contract, and bench-time cost of running EuroFlow panels versus conventional 8-colour cytometers
- FCS exports drop into FlowJo and other existing analysis tools for compatibility with current workflows
- Blinded side-by-side validation protocol for labs to test concordance on their own residual samples